Duffy DuFresne is a Harvard-educated business leader with an extensive background in the biopharmaceutical industry. Throughout his career, he has held various executive positions in well-known companies such as Pacgen Biopharmaceuticals, Zelos Therapeutics, and Ischemix. DuFresne is also a seasoned consultant with years of experience advising companies on a wide range of issues, including business development, marketing, and operations. He currently serves as the General Partner at Alignment Ventures, a venture capital firm that invests in early-stage healthcare companies.

DuFresne received a Master of Business Administration and a Bachelor of Arts in History from Harvard University. He has held senior leadership roles in marketing, business development, and international operations at multinational corporations such as Boots Pharmaceutical and Baxter International Inc.

As a business leader, DuFresne has experience leading companies through various stages of growth, from startups to public companies. He has an in-depth understanding of the biopharmaceutical industry, particularly in drug development and commercialization. He is passionate about finding ways to bring innovative new therapies to patients in need.